Vasopressiinin vaikutus munuaisten toimintaan sydänleikkauksen jälkeisessä vasodilatoivassa shokissa

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2007-001816-22-FI

Enrollment

Registered

2007-08-30

Start date

2007-10-19

Completion date

Unknown

Last updated

2020-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sydänleikkauspotilaita, joilla on perfuusion jälkeinen vasodilatoiva shokki MedDRA version: 9.1 Level: LLT Classification code 10048348 Term: Hypotension aggravated

Interventions

Trade Name: Pitressin Pharmaceutical Form: INN or Proposed INN: argipressin Pharmaceutical form of the placebo: Solution for infusion Ro

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026